⌘K

Home/Filings/4/0001181431-12-016290

4//SEC Filing

Bartizal Ken 4

Accession 0001181431-12-016290

CIK 0001356857other

View on SEC.gov Company Profile

Filed

Mar 11, 8:00 PM ET

Accepted

Mar 12, 3:05 PM ET

Size

5.1 KB

Accession

0001181431-12-016290

Insider Transaction Report

Form 4

Period: 2012-03-08

Trius Therapeutics IncTSRX

Chief Development Officer

Transactions

Award
Stock Option (right to buy)
2012-03-08+75,000→ 75,000 total
Exercise: $4.80Exp: 2022-03-07→ Common Stock (75,000 underlying)

Footnotes (1)

[F1]The option vests in 48 successive equal monthly installments over the four year period beginning on March 8, 2012.

Documents

1 file

4
rrd338210.xmlPrimary
FORM 4

Issuer

Trius Therapeutics Inc

CIK 0001356857

Entity typeother

Related Parties

1

filerCIK 0001478832

Filing Metadata

Form type: 4
Filed: Mar 11, 8:00 PM ET
Accepted: Mar 12, 3:05 PM ET
Size: 5.1 KB

View on SEC.gov